Chapter 13 - Diseases of the musculoskeletal system and connective tissue (M00-M99)»Systemic connective tissue disorders (M30-M36)»Systemic lupus erythematosus, unspecified (M32.9)
M32.9
Systemic lupus erythematosus, unspecified
Related indications (MeSH) (1)
Lupus Erythematosus, Systemic362 drugs (137 approved, 225 experimental)
A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.